Swedencare AB (publ)

OM:SECARE Stock Report

Market Cap: SEK 3.7b

Swedencare Future Growth

Future criteria checks 4/6

Swedencare is forecast to grow earnings and revenue by 47% and 8.9% per annum respectively. EPS is expected to grow by 47% per annum. Return on equity is forecast to be 4.7% in 3 years.

Key information

47.0%

Earnings growth rate

47.01%

EPS growth rate

Pharmaceuticals earnings growth35.4%
Revenue growth rate8.9%
Future return on equity4.72%
Analyst coverage

Low

Last updated23 Mar 2026

Recent future growth updates

Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next

Feb 15
Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next

Recent updates

Online And Pharma Execution Risks Will Test Pet Health Upside Potential

Catalysts About Swedencare Swedencare develops and sells pet health products across dental care, nutraceuticals, treats and veterinary pharma, with a growing focus on online and Big Box retail channels. What are the underlying business or industry changes driving this perspective?

Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next

Feb 15
Swedencare AB (publ) Just Missed EPS By 9.9%: Here's What Analysts Think Will Happen Next

The Compound Effect: From Acquisition to Integration

In 2026, the story is no longer about how many companies Swedencare can buy, but how effectively it can scale its existing brands (ProDen PlaqueOff and NaturVet) into global Big Box retail and e-commerce The Pet Humanization Play Swedencare's narrative rests on three pillars: The Global Brand Portfolio: Moving from a single product company to a diversified pet health giant. The story is about cross-selling, taking a successful dental product from Sweden and putting it in 2,000 Walmart stores in the US The Channel Pivot: Swedencare is taking direct control of its destiny by moving Amazon sales inhouse and entering Big Box retail like Walmart, CVS etc.

Big Box Expansion And Soft Chew Capacity Will Transform Long Term Pet Health Prospects

Catalysts About Swedencare Swedencare develops and sells pet health products and provides contract development and manufacturing services to animal health companies. What are the underlying business or industry changes driving this perspective?

With A 37% Price Drop For Swedencare AB (publ) (STO:SECARE) You'll Still Get What You Pay For

Feb 01
With A 37% Price Drop For Swedencare AB (publ) (STO:SECARE) You'll Still Get What You Pay For

We Think Swedencare's (STO:SECARE) Solid Earnings Are Understated

Oct 30
We Think Swedencare's (STO:SECARE) Solid Earnings Are Understated

Swedencare AB (publ) Reported A Surprise Loss, And Analysts Have Updated Their Forecasts

Jul 26
Swedencare AB (publ) Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
User avatar

Resolving NaturVet's Challenges And Global Expansion Will Enhance Future Opportunities

Improved growth strategy for NaturVet and global market expansion aim to enhance revenue and achieve group targets.

Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?

Apr 29
Does Swedencare (STO:SECARE) Deserve A Spot On Your Watchlist?

Swedencare (STO:SECARE) Seems To Use Debt Quite Sensibly

Dec 20
Swedencare (STO:SECARE) Seems To Use Debt Quite Sensibly

Earnings and Revenue Growth Forecasts

OM:SECARE - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20283,4383365506012
12/31/20273,2092704765713
12/31/20262,8861614024342
12/31/20252,69556276327N/A
9/30/20252,67563313364N/A
6/30/20252,60365292337N/A
3/31/20252,58793310385N/A
12/31/20242,54099288359N/A
9/30/20242,50462338404N/A
6/30/20242,47276351414N/A
3/31/20242,41472381415N/A
12/31/20232,33859408444N/A
9/30/20232,20887410444N/A
6/30/20232,08553332376N/A
3/31/20231,98797257314N/A
12/31/20221,84395193260N/A
9/30/20221,6009896170N/A
6/30/20221,33510569135N/A
3/31/20221,01960114161N/A
12/31/20217735598126N/A
9/30/20216184090106N/A
6/30/2021465447479N/A
3/31/2021337344548N/A
12/31/2020240333637N/A
9/30/2020174342629N/A
6/30/2020136282831N/A
3/31/2020134302024N/A
12/31/2019127302833N/A
9/30/201912130N/A32N/A
6/30/201911328N/A30N/A
3/31/201910827N/A28N/A
12/31/20189923N/A22N/A
9/30/20189423N/A21N/A
6/30/20189220N/A15N/A
3/31/20188517N/A14N/A
12/31/20178617N/A13N/A
9/30/20177812N/A4N/A
6/30/20177011N/A4N/A
3/31/20176312N/A4N/A
12/31/20165410N/A2N/A
9/30/2016439N/A8N/A
6/30/2016378N/A9N/A
3/31/2016348N/A5N/A
12/31/2015277N/A4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SECARE's forecast earnings growth (47% per year) is above the savings rate (1.8%).

Earnings vs Market: SECARE's earnings (47% per year) are forecast to grow faster than the Swedish market (9.4% per year).

High Growth Earnings: SECARE's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: SECARE's revenue (8.9% per year) is forecast to grow faster than the Swedish market (0.9% per year).

High Growth Revenue: SECARE's revenue (8.9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SECARE's Return on Equity is forecast to be low in 3 years time (4.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/24 10:14
End of Day Share Price 2026/03/24 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Swedencare AB (publ) is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Johan BrownABG Sundal Collier Sponsored
Adela DashianJefferies LLC
Adrian ElmlundNordea Markets